Myrofora Panagi

1.5k total citations · 1 hit paper
24 papers, 883 citations indexed

About

Myrofora Panagi is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Myrofora Panagi has authored 24 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomedical Engineering, 11 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Myrofora Panagi's work include Nanoplatforms for cancer theranostics (12 papers), Ultrasound and Hyperthermia Applications (7 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). Myrofora Panagi is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Ultrasound and Hyperthermia Applications (7 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). Myrofora Panagi collaborates with scholars based in Cyprus, Japan and United States. Myrofora Panagi's co-authors include Triantafyllos Stylianopoulos, Panagiotis Papageorgis, Christiana M. Neophytou, Fotios Mpekris, Chrysovalantis Voutouri, John D. Martin, Horacio Cabral, Andreas Stylianou, Anastasia Constantinidou and Christina Michael and has published in prestigious journals such as ACS Nano, Development and Cancer Research.

In The Last Decade

Myrofora Panagi

24 papers receiving 872 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities

2021 286 citations Christiana M. Neophytou, Myrofora Panagi et al. Cancers profile →

Peers

Myrofora Panagi

ONCOL

IMMUN

Lifeng Tian United States

Siddarth Chandrasekaran United States

Christina Hartl United States

May Tun Saung United States

Yuan‐Tong Liu China

Md Zahidul Islam Pranjol United Kingdom

Sabina Pozzi Israel

Lanlan Hui China

Matthew Ibbs Poland

Lifeng Tian United States

Myrofora Panagi

402 ×1.3

ONCOL

431 ×1.5

187 ×0.6

150 ×0.7

IMMUN

99 ×0.7

Citations per year, relative to Myrofora Panagi Myrofora Panagi (= 1×) peers Lifeng Tian

Countries citing papers authored by Myrofora Panagi

Since Specialization

Citations

This map shows the geographic impact of Myrofora Panagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myrofora Panagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myrofora Panagi more than expected).

Fields of papers citing papers by Myrofora Panagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myrofora Panagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myrofora Panagi. The network helps show where Myrofora Panagi may publish in the future.

Co-authorship network of co-authors of Myrofora Panagi

This figure shows the co-authorship network connecting the top 25 collaborators of Myrofora Panagi. A scholar is included among the top collaborators of Myrofora Panagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myrofora Panagi. Myrofora Panagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Voutouri, Chrysovalantis, et al.. (2025). Sonopermeation combined with stroma normalization enables complete cure using nano-immunotherapy in murine breast tumors. Journal of Controlled Release. 382. 113722–113722. 2 indexed citations

Mpekris, Fotios, Myrofora Panagi, Chrysovalantis Voutouri, et al.. (2024). Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas. Molecular Cancer Therapeutics. 23(11). 1555–1567. 6 indexed citations

Mpekris, Fotios, et al.. (2024). A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas. Neoplasia. 51. 100990–100990. 9 indexed citations

Mpekris, Fotios, et al.. (2024). Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy. Cell Reports Medicine. 5(7). 101626–101626. 19 indexed citations

Panagi, Myrofora, Fotios Mpekris, Chrysovalantis Voutouri, et al.. (2024). Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition. Clinical Cancer Research. 30(11). 2582–2597. 15 indexed citations

Theodorou, Ioannis G., Fotios Mpekris, Paris Papagiorgis, et al.. (2023). Gold Nanobipyramids for Near-Infrared Fluorescence-Enhanced Imaging and Treatment of Triple-Negative Breast Cancer. Cancers. 15(14). 3693–3693. 6 indexed citations

Panagi, Myrofora, et al.. (2023). Exploring the landscape of immunotherapy approaches in sarcomas. Frontiers in Oncology. 12. 1069963–1069963. 5 indexed citations

Voutouri, Chrysovalantis, Fotios Mpekris, Myrofora Panagi, et al.. (2023). Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy. Acta Biomaterialia. 167. 121–134. 26 indexed citations

Mpekris, Fotios, Chrysovalantis Voutouri, Myrofora Panagi, et al.. (2022). Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy. Journal of Controlled Release. 345. 190–199. 43 indexed citations

10.

Mpekris, Fotios, Myrofora Panagi, Christina Michael, et al.. (2022). Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment. Journal of Controlled Release. 353. 956–964. 15 indexed citations

11.

Panagi, Myrofora, et al.. (2022). Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness. Theranostics. 12(14). 6106–6129. 31 indexed citations

12.

Voutouri, Chrysovalantis, Triantafyllos Stylianopoulos, Fotios Mpekris, et al.. (2022). 108 Prediction of cancer immunotherapy response using ultrasound imaging of tumor stiffness and perfusion. Regular and Young Investigator Award Abstracts. A118–A118. 1 indexed citations

13.

Voutouri, Chrysovalantis, Myrofora Panagi, Fotios Mpekris, et al.. (2021). Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response. Advanced Therapeutics. 4(9). 31 indexed citations

14.

Neophytou, Christiana M., Myrofora Panagi, Triantafyllos Stylianopoulos, & Panagiotis Papageorgis. (2021). The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities. Cancers. 13(9). 2053–2053. 286 indexed citations breakdown →

15.

Panagi, Myrofora, et al.. (2020). Evidence of two types of balance between stem cell mitosis and enterocyte nucleus growth in the Drosophila midgut. Development. 147(11). 21 indexed citations

16.

Kralj, Slavko, Xenofon Karagiorgis, Ioanna Savva, et al.. (2020). Multifunctional Gas and pH Fluorescent Sensors Based on Cellulose Acetate Electrospun Fibers Decorated with Rhodamine B-Functionalised Core-Shell Ferrous Nanoparticles. Scientific Reports. 10(1). 367–367. 48 indexed citations

17.

Mpekris, Fotios, Myrofora Panagi, Chrysovalantis Voutouri, et al.. (2020). Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis. Advanced Science. 8(3). 2001917–2001917. 84 indexed citations

18.

Panagi, Myrofora, Chrysovalantis Voutouri, Fotios Mpekris, et al.. (2020). TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity. Theranostics. 10(4). 1910–1922. 154 indexed citations

19.

Kalli, Maria, Fotios Mpekris, Chen Khuan Wong, et al.. (2019). Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis. Frontiers in Oncology. 9. 32–32. 32 indexed citations

20.

Panagi, Myrofora, et al.. (2019). Unpredictable Effects of the Genetic Background of Transgenic Lines in Physiological Quantitative Traits. G3 Genes Genomes Genetics. 9(11). 3877–3890. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact